Burlington, Mass. – (May 21, 2013) – Baylis Medical, a leading supplier of high-technology interventional cardiology and radiology products, is pleased to announce the official opening of its new offices in Burlington, Mass. The opening of the Boston-area office is a part of Baylis Medical’s ongoing global expansion project. Baylis Medical currently employs 200 employees globally and plans to hire additional employees this year.

Baylis Medical’s business has grown substantially over the past 24 months with an expanding sales force and the successful launch of several new products. The Boston office expansion was warranted by this growth. “The new office represents our commitment towards our continued growth in the U.S. market through direct sales, strengthened operational capabilities and enhanced technical support,” said Frank Baylis, President.

The new office will also bring in new opportunities for Baylis Medical. “Boston is a hub of medical device activities, and we are looking forward to tapping into the local expertise as we continue to expand our presence,” noted Baylis. “We will be looking to recruit more members to our team in the near future.”

Through the Massachusetts Life Sciences Center, Massachusetts is investing $1 billion over 10 years in the growth of the state’s life sciences supercluster. These investments are being made under the Massachusetts Life Sciences Initiative, proposed by Governor Patrick in 2007, and passed by the State Legislature and signed into law by Governor Patrick in 2008.

Massachusetts officials first met with Baylis Medical at the AdvaMed 2012 conference in Boston last October. “Congratulations to Baylis Medical on the opening of its first U.S. office,” said Susan Windham-Bannister, Ph.D., President & CEO of the Massachusetts Life Sciences Center (MLSC). “We are pleased that the company has chosen Massachusetts as the home for its U.S. operations. The company's portfolio of products, ranging from chronic pain management to radiology, are a great addition to our life sciences community, and we are confident that Massachusetts is the best place for Baylis Medical to continue to grow its business.”

“Burlington is pleased to welcome Baylis and its employees to town, and we hope they fully immerse themselves in all that Burlington has to offer,” said Massachusetts State Representative Kenneth I. Gordon. “The opening of Baylis Medical’s location demonstrates the recognition of Burlington as an important high tech center.”

“Baylis Medical has discovered what scores of other medtech companies now know – Massachusetts is a great place to establish a foothold in the American medical market,” said Tom Sommer, President of the Massachusetts Medical Device Industry Council (MassMEDIC). “We welcome the expansion of yet another Canadian medical device company in Massachusetts.”

“I join the Governor in welcoming Baylis Medical to Massachusetts,” said Tom Gradel, Acting Director of the Massachusetts Office of International Trade & Investment. “Baylis Medical will join a broad and deep ecosystem in the global hub of life sciences.”

Baylis Medical’s new office is located at the following address:

50 Mall Road

Suite G18

Burlington, MA 01803

About Baylis Medical

Baylis Medical develops and markets high-technology medical devices used in the fields of interventional cardiology and interventional radiology. The company’s core expertise lies in electrosurgical systems that are used to deliver various therapeutic treatments. The company has offices in Montreal, Toronto, Vancouver, London, U.K. and Boston, Mass. For more information, visit www.baylismedical.com.

About the Massachusetts Life Sciences Center

The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency of the Commonwealth of Massachusetts tasked with implementing the Massachusetts Life Sciences Act, a 10-year, $1-billion initiative that was signed into law in June of 2008. The MLSC’s mission is to create jobs in the life sciences and support vital scientific research that will improve the human condition. This work includes making financial investments in public and private institutions that are advancing life sciences research, development and commercialization as well as building ties among sectors of the Massachusetts life sciences community. For more information, visit www.masslifesciences.com.